Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Authors
von Haehling, StephanSchefold, Joerg C.
Jankowska, Ewa A.
Springer, Jochen
Vazir, Ali
Kalra, Paul R.
Sandek, Anja
Fauler, Günter
Stojakovic, Tatjana
Trauner, Michael
Ponikowski, Piotr
Volk, Hans-Dieter
Doehner, Wolfram
Coats, Andrew J.S.
Poole-Wilson, Philip A.
Anker, Stefan D.
Affiliation
Charité Medical SchoolMilitary Hospital, Wroclaw
University of East Anglia
National Heart and Lung Institute
Portsmouth Hospitals NHS Trust
Medical University of Graz
Medical University of Vienna
IRCCS San Raffaele
Issue Date
2012-02-07
Metadata
Show full item recordAbstract
This study sought to assess the effects of ursodeoxycholic acid (UDCA) on endothelial function and inflammatory markers in patients with chronic heart failure (CHF).Citation
von Haehling, S. et al (2012) 'Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial' J. Am. Coll. Cardiol. 59 (6):585-92Publisher
American College of CardiologyPubMed ID
22300693Additional Links
http://content.onlinejacc.org/article.aspx?articleid=1201106Type
ArticleLanguage
enISSN
1558-3597ae974a485f413a2113503eed53cd6c53
10.1016/j.jacc.2011.10.880
Scopus Count
Collections
Related articles
- Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
- Authors: Mayer B, Holmer SR, Hengstenberg C, Lieb W, Pfeifer M, Schunkert H
- Issue date: 2005 Aug 18
- Exercise training in patients with advanced chronic heart failure (NYHA IIIb) promotes restoration of peripheral vasomotor function, induction of endogenous regeneration, and improvement of left ventricular function.
- Authors: Erbs S, Höllriegel R, Linke A, Beck EB, Adams V, Gielen S, Möbius-Winkler S, Sandri M, Kränkel N, Hambrecht R, Schuler G
- Issue date: 2010 Jul
- Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
- Authors: Toblli JE, Lombraña A, Duarte P, Di Gennaro F
- Issue date: 2007 Oct 23
- Effects of 5'-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial.
- Authors: Behling A, Rohde LE, Colombo FC, Goldraich LA, Stein R, Clausell N
- Issue date: 2008 Apr
- Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure.
- Authors: Gavin AD, Struthers AD
- Issue date: 2005 Jun